Methyl Donor Micronutrients: A Potential Dietary Epigenetic Target in Systemic Lupus Erythematosus Patients.
Karen Pesqueda-CendejasBertha Campos-LópezPaulina E Mora-GarcíaJosé Miguel Moreno-OrtizUlises de la Cruz-MossoPublished in: International journal of molecular sciences (2023)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by an aberrant immune response and persistent inflammation. Its pathogenesis remains unknown; however, a complex interaction between environmental, genetic, and epigenetic factors has been suggested to cause disease onset. Several studies have demonstrated that epigenetic alterations, such as DNA hypomethylation, miRNA overexpression, and altered histone acetylation, may contribute to SLE onset and the disease's clinical manifestations. Epigenetic changes, especially methylation patterns, are modifiable and susceptible to environmental factors such as diet. It is well known that methyl donor nutrients, such as folate, methionine, choline, and some B vitamins, play a relevant role in DNA methylation by participating as methyl donors or coenzymes in one-carbon metabolism. Based on this knowledge, this critical literature review aimed to integrate the evidence in animal models and humans regarding the role of nutrients in epigenetic homeostasis and their impact on immune system regulation to suggest a potential epigenetic diet that could serve as adjuvant therapy in SLE.
Keyphrases
- dna methylation
- systemic lupus erythematosus
- genome wide
- gene expression
- disease activity
- immune response
- copy number
- end stage renal disease
- physical activity
- weight loss
- healthcare
- oxidative stress
- heavy metals
- newly diagnosed
- rheumatoid arthritis
- multiple sclerosis
- chronic kidney disease
- single molecule
- case report
- cell proliferation
- peritoneal dialysis
- inflammatory response
- drug induced